Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert K. Baker is active.

Publication


Featured researches published by Robert K. Baker.


Bioorganic & Medicinal Chemistry Letters | 1995

Piperidine-ether based hNK1 antagonists 2: Investigation of the effect of N-substitution

Timothy Harrison; Andrew Pate Owens; Brian John Williams; Christopher John Swain; Robert K. Baker; Peter H. Hutson; Sharon Sadowski; Margaret A. Cascieri

Abstract The effect of nitrogen substitution on the binding affinity of the piperidine-ether substance P antagonist L-733,060 for the hNK 1 receptor and L-type Ca 2+ channel is discussed.


Bioorganic & Medicinal Chemistry Letters | 1997

3-benzyloxy-2-phenylpiperidine NK1 antagonists: The influence of alpha methyl substitution

Christopher John Swain; Brian John Williams; Robert K. Baker; Margaret A. Cascieri; Gary G. Chicchi; Michael J. Forrest; Richard H. Herbert; L. Keown; Tammy Ladduwahetty; Sylvie Luell; D. E. Macintyre; Joe Metzger; S. Morton; Andrew Pate Owens; Sharon Sadowski; Alan P. Watt

Abstract In vitro metabolism studies on a series of 3,5-bis(trifluoromethyl)benzyl ethers have identified 3,5-bis(trifluoromethyl)benzoic acid as a significant metabolite possibly arising via oxidation of the benzylic position. A methyl group was introduced in an effort to suppress this route of metabolism. One diastereoisomer displayed an increase in affinity and a marked improvement in duration of action. In vitro metabolism studies on a series of 3,5-bis(trifluoromethyl)benzyl ethers have identified 3,5-bis(trifluoromethyl)benzoic acid as a significant metabolite possibly arising via oxidation at the benzylic position. A methyl group was introduced in an effort to suppress this route of metabolism. One diastereoisomer displayed an increase in affinity and a marked improvement in duration of action


Bioorganic & Medicinal Chemistry Letters | 1993

Quinuclidine based NK-1 antagonists 2: determination of the absolute stereochemical requirements

Christopher John Swain; Eileen Mary Seward; Verity Margaret Sabin; Simon Neil Owen; Robert K. Baker; Margaret A. Cascieri; Sharon Sadowski; Catherine D. Strader; Richard G. Ball

Abstract The relative and absolute stereochemical requirements for high affinity binding to the human NK-1 receptor are defined for a series of quinuclidine ethers. Whilst the S stereochemistry at C-3 is essential for high afifnity, surprising both epimers at C-2 are active.


Bioorganic & Medicinal Chemistry Letters | 1995

Phenyl-glycinol based NK1 receptor antagonists — towards the minimum pharmacophore

Andrew Pate Owens; Brian John Williams; Timothy Harrison; Christopher John Swain; Robert K. Baker; Sharon Sadowski; Margaret A. Cascieri

The effects of alternative benzyl ether substitution and the introduction of steric constraints on the binding affinity for the hNK1 receptor of a phenylglycinol based Substance P antagonist is described.


Tetrahedron Letters | 1998

Synthetic studies on the immunosuppressive agent FK-506: Enantioselective synthesis of a C22C34 fragment

Robert K. Baker; Kathleen M. Rupprecht; David M. Armistead; Joshua S. Boger; Robert A. Frankshun; Paul J. Hodges; Karst Hoogsteen; Judith M. Pissano; Bruce E. Witzel

Abstract The C28C32 cyclohexyl group of the natural product, FK-506, was prepared enantioselectively from the iodolactone by replacement of iodide with retention of configuration . The C27C28 trisubstituted olefin was introduced stereoselectively via a classical aldol/elimination sequence employing titanium enolate methodology. Elaboration of this chemistry has led to a synthesis of a C22C34 fragment of the natural product.


Bioorganic & Medicinal Chemistry Letters | 1992

Inhibitors of myo-inositol monophosphatase unrelated to the enzyme substrate

Stephen Robert Fletcher; Robert K. Baker; Paul D. Leeson; Martin Richard Teall; E.A. Harley; C.I. Ragan

Abstract Hydroxymethylenebisphosphonate derivatives have been found to be competitive inhibitors of myo-inositol monophosphatase.


Tetrahedron Letters | 1998

Synthetic studies on the immunosuppressive agent FK-506: Construction of the polycarbonyl region

Kathleen M. Rupprecht; Robert K. Baker; Joshua S. Boger; Alita A. Davis; Paul J. Hodges; Joanne F. Kinneary

Abstract The C10C17 fragment of the natural product, FK-506, has been stereoselectively synthesized from L-gulose. Methods for elaboration to the C1C17 fragment and installation of the C9 carbonyl group are described.


Cellular Immunology | 1999

Correolide and Derivatives Are Novel Immunosuppressants Blocking the Lymphocyte Kv1.3 Potassium Channels

Gloria C. Koo; Joseph T. Blake; Kashmira Shah; Mary Jo Staruch; Francis J. Dumont; Denise Wunderler; Manuel Sanchez; Owen B. McManus; Anna Sirotina-Meisher; Paul Fischer; Robert C. Boltz; Michael A. Goetz; Robert K. Baker; Jianming Bao; Frank Kayser; Kathleen M. Rupprecht; William H. Parsons; Xinchun Tong; Ida Ita; Jim Pivnichny; Stella H. Vincent; Paul K. Cunningham; Don Hora; William P. Feeney; Gregory J. Kaczorowski; Martin S. Springer


Archive | 1996

Triterpene derivatives with immunosuppressant activity

Robert K. Baker; Frank Kayser; Jianming Bao; William H. Parsons; Kathleen M. Rupprecht


Archive | 1999

Carbocyclic potassium channel inhibitors

Robert K. Baker; Jianming Bao; Jennifer Chee; Maria L. Garcia; Gregory J. Kaczorowski; Frank Kayser; Andrew Kotliar; Chou Juitsai Liu; Shouwu Miao; William H. Parsons; Kathleen M. Rupprecht; William A. Schmalhofer; Christopher F. Claiborne; David A. Claremon; Nigel Liverton; Wayne J. Thompson

Collaboration


Dive into the Robert K. Baker's collaboration.

Researchain Logo
Decentralizing Knowledge